NPRA1985

NPRA1985 | Joined since 2020-09-03

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

3,415

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
3,415
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-10-20 22:53 | Report Abuse

The emergency use of vaccine candidates has followed a rigorous review and approval procedure in China and is accordance with the WHO rules, and so far, all those who have received the vaccines under the emergency use plan have shown no severe adverse reactions, Zheng Zhongwei, an official from the National Health Commission in charge of technology development, told a press conference on Tuesday.

After approval of the emergency use in China, China also briefed the representative office of the World Health Organization on the matter to obtain their ratification and support, the official added.

In response to questions about whether the urgent use of vaccines is actually necessary or too risky, the official said the second wave of the pandemic around the world poses great challenges to China, and the emergency vaccination is necessary, which aims to protect those facing higher infection risks — including frontline medical workers, border control staff, those who work overseas and public services personnel. Those who went abroad received their vaccinations voluntarily in China in accordance with related rules.

Concerning vaccine candidates' possible adverse effects, some side effects are common and normal for a vaccine still under development, with mild adverse effects such as swelling of the vaccination spot and fever reported by some of the 60,000 people vaccinated, but no severe situations have been recorded, according to the conference.

https://www.globaltimes.cn/content/1204085.shtml

Stock

2020-10-20 22:36 | Report Abuse

Western front-runners like Johnson & Johnson and AstraZeneca Plc have temporarily halted their clinical trials in recent months after unexplained illnesses in participants.

Representatives for both Sinovac and China National Biotec’s parent, Sinopharm, said at the briefing that there had been no reports of participants in their ongoing Phase III vaccine trials experiencing serious adverse reactions. The companies have enrolled more than 50,000 people worldwide in the tests.

https://www.google.com/amp/s/www.livemint.com/science/news/china-justifies-giving-covid-vaccines-to-thousands-before-final-trial-results/amp-11603197243336.html

Stock

2020-10-20 22:32 | Report Abuse

A state-owned Chinese drugmaker is setting up production lines to supply 1 billion doses of two possible coronavirus vaccines that are being tested on 50,000 people in 10 countries, the company chairman said Tuesday.

https://www.google.com/amp/s/abc3340.com/amp/news/coronavirus/chinese-drugmaker-setting-up-vaccine-production-lines

Stock

2020-10-20 22:01 | Report Abuse

China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021, Chairman Liu Jingzhen said on Tuesday.


About 60,000 people have received Chinese coronavirus vaccine candidates during Phase III clinical trials, with no serious side effects reported so far, Tian Baoguo, an official at China's Ministry of Science and Technology, said at the same government media briefing.

In addition, hundreds of thousands of people in China have been given experimental trial-stage vaccines as part of an emergency inoculation programme launched in July.

https://www.thestar.com.my/news/world/2020/10/20/sinopharm-says-may-be-able-to-make-over-1-billion-coronavirus-vaccine-doses-in-2021

Stock

2020-10-20 21:47 | Report Abuse

Sinopharm will make 15 million doses of its dual-dose vaccine this year, and five million doses will begin to arrive in Indonesia by next month.

https://www.aa.com.tr/en/asia-pacific/indonesian-team-in-china-to-check-covid-19-vaccines/2008887

Stock

2020-10-20 20:35 | Report Abuse

Good lo lucky you managed to buy at cheaper price

Stock

2020-10-20 19:31 | Report Abuse

If that’s the case why are you still here in this forum why not take profit first ? Kekeke

Stock

2020-10-20 19:27 | Report Abuse

@rezzare oh wait you already have 30% profit from this share so you can afford to talk big kekeke

Stock

2020-10-20 19:25 | Report Abuse

@rezzare Everyone has got a cut loss point . Don’t you have one ?zzzz I never said I gave up on this stock . I will just monitor and and buy back lower if necessary

Stock

2020-10-20 18:06 | Report Abuse

This stock really tests your holding power. Have to monitor closely in case drop, i will sell first and and buy back lower.

Stock

2020-10-20 11:10 | Report Abuse

Nope i disagree. It is not fully reflected yet. Once the Sinopharm vaccine is approved and distribution starts, it will be a different story altogether. This is just my personal opinion.

Stock

2020-10-20 11:05 | Report Abuse

Like nothing better to do kekeke

Stock

2020-10-20 11:04 | Report Abuse

Anyway what is that reezdragon85 fella doing on this forum if he doesnt believe in this stock? What his hidden agenda? kekeke

Stock

2020-10-20 10:55 | Report Abuse

Yea i collected some more at lower price

Stock

2020-10-20 10:48 | Report Abuse

@BigPortfolio still here. Holding no matter what. If you guys no patience can play other stocks first.

Stock

2020-10-20 09:14 | Report Abuse

Hope it will close at 0.210 at least by the end of this week.

Stock

2020-10-20 09:10 | Report Abuse

Should overtake hlt again soon

Stock
Stock
Stock

2020-10-20 09:05 | Report Abuse

Hope to enter this counter as well

Stock

2020-10-20 01:50 | Report Abuse

“There have also been reports of major pharmaceutical companies such as Johnson & Johnson and AstraZeneca pausing their vaccine trial on safety concerns."

https://webcache.googleusercontent.com/search?q=cache:LV7bqcwk2E4J:https://www.thestar.com.my/business/business-news/2020/10/19/gloves-stay-strong-with-fears-over-vaccines-safety+&cd=2&hl=en&ct=clnk&gl=my

Stock

2020-10-20 01:47 | Report Abuse

The Johnson & Johnson trial was put on hold October 12 due to a study participant's "unexplained illness," according to a company statement last week. Johnson & Johnson voluntarily stopped enrolling study participants while the illness is being reviewed by an independent monitoring board.
The company and the FDA declined to answer two questions from CNN: One, whether the study volunteer who became ill received the vaccine or the placebo, and two, if this is the first pause for the trial.

The Johnson & Johnson vaccine and the AstraZeneca vaccine both use an adenovirus as part of its Covid-19 vaccine. Adenoviruses cause the common cold and other illnesses, but the viruses are
genetically modified so they won't replicate and cause disease, according to the companies.

Johnson & Johnson uses a human adenovirus, and the vaccine from AstraZeneca and Oxford uses a chimpanzee adenovirus.

Volunteers in the trial run by AstraZeneca and the University of Oxford developed "unexplained neurological symptoms including changed sensation and limb weakness," according to a participant information sheet from the university.

The AstraZeneca trial paused once in July and again in September because of illnesses. The September pause is still in effect in the United States.

https://edition.cnn.com/2020/10/19/health/johnson-and-johnson-vaccine-trial-transparency/index.html

Stock

2020-10-19 22:38 | Report Abuse

"Hishammuddin also said that Malaysia is monitoring the development of the vaccine closely, adding that GETTING THE VACCINE IS A MATTER OF HIGH PRIORITY for the government.

"If we want to find a way forward in dealing with COVID-19 there are only two ways into it, one is to prevent by vaccination, the other is to cure by medication," he said.

China has said that the vaccine could be ready for use by the general public as early as NOVEMBER, he added."

https://www.channelnewsasia.com/news/asia/malaysia-china-covid-19-vaccine-priority-list-wang-yi-13271934

Stock

2020-10-19 22:28 | Report Abuse

Chief innovation officer at the University of Hong Kong, Yiwu He reportedly said that Xi Jinping’s goal was to have a vaccine approved ahead of the US, and China’s National Biotec Group, or C.N.B.G, known as the country’s largest vaccine manufacturer gave some level of approval to the vaccine for October. The company, that had 2 EXPERIMENTAL VACCINES in the PHASE III TRIAL signed documents with China’s regulatory commission, ACCELARATING THE PROCESS which otherwise takes between 6 months to a year.

https://www.republicworld.com/world-news/rest-of-the-world-news/china-extends-emergency-use-authorization-of-covid-19-vaccine.html

Stock

2020-10-19 21:17 | Report Abuse

"U.S. Stock Futures Rise on Stimulus Talks, China’s Growth

Over the weekend, House Speaker Nancy Pelosi told the White House it had until Tuesday to reach a deal with Democrats. If the deadline passes without a deal, ongoing talks would be increasingly unlikely to produce sweeping relief legislation worth trillions of dollars within the next two weeks, her aide suggested. Mrs. Pelosi and Treasury Secretary Steven Mnuchin spoke Saturday night, but a number of differences remain.

Chinese officials said Monday that gross domestic product expanded by 4.9% in the third quarter from a year earlier, putting China’s economy back toward its pre-coronavirus trajectory half a year after the pandemic gutted its economy. Other economic indicators released Monday offered additional signs of strength: China’s headline unemployment figure, the urban surveyed jobless rate, fell to 5.4% in September. "

https://www.wsj.com/articles/global-stock-markets-dow-update-10-19-2020-11603100257

Stock

2020-10-19 21:05 | Report Abuse

Why calvin refers to himself as calvin?

Stock

2020-10-19 20:30 | Report Abuse

"The World Health Organization (WHO) is working with China on requirements for international approval of any Chinese COVID-19 vaccine, a senior official said on Monday according to Reuters.

"WHO's office in China and WHO headquarters has been working with the regulatory authorities in China," assistant director-general Mariangela Simao told a briefing in Geneva. "We are in direct contact, we have been sharing information and the requirements for international approval of vaccines."

https://www.thestar.com.my/aseanplus/aseanplus-news/2020/09/08/who-working-with-china-on-requirements-for-covid-19-vaccine-approval

Stock

2020-10-19 19:48 | Report Abuse

@BigBladd Yes apparently there are not one but TWO inactivated covid vaccines, one of which was co-developed by Sinopharm and Wuhan Institute of Biological Products and the other was co-developed by Sinopharm and Beijing Institute of Biological Products, both of which are currently in Phase 3 multicentre clinical trials.

Stock

2020-10-19 19:42 | Report Abuse

"Covid-19 vaccine on trial in UAE found safe in early stages: Study

The Phase I and II of BBIBP-CorV vaccine for Covid-19 is found to be safe and produce an immune response, according to the latest study published in THE LANCET Infectious Diseases journal.

The vaccine candidate is developed by China National Biotec Group (CNBG) and the Beijing Institute of Biological Products. The study based on Phase I and II is done by the researchers at the CNBG subsidiary, Chinese disease control authorities and other research institutes.

The study pointed out that the results of the Phase III trial of BBIBP-CorV vaccine currently underway in Abu Dhabi will provide information on whether this vaccine is safe and efficacious against SARS-CoV-2 infection, and for how long the protective effect is maintained. The human trial underway in the UAE is through a partnership between SINOPHARM's CNBG and Abu Dhabi-based Group 42 (G42) under the supervision of the Department of Health of Abu Dhabi.

The vaccine candidate is developed by China National Biotec Group (CNBG) and the Beijing Institute of Biological Products. The study based on Phase I and II is done by the researchers at the CNBG subsidiary, Chinese disease control authorities and other research institutes."

https://www.khaleejtimes.com/coronavirus-pandemic/chinese-covid-19-vaccine-found-to-be-safe-on-humans-study

Stock

2020-10-19 19:37 | Report Abuse

"Sputnik V vs. Sinopharm’s Vaccines? Egypt Purportedly Opting for Sinopharm

The Egyptian government also has secured 30 million doses of AZD1222 from AstraZeneca. But for access to the technology to produce a COVID-19 vaccine for internal use and export, it would appear China’s Sinopharm is well-positioned.

Although without outright declaring so, Egypt places its bet on the Chinese vaccines as more ready for primetime over the Russian one that happens to be approved (in Russia). Hossam Hosni, who leads a COVID-19 scientific committee, mentioned to Al-Monitor over a telephone call that Egypt will work with China commenting, “Egypt has verified the safety and prevention measures of the two [Chinese] vaccines it announced clinical trials for. “

This is one of the reasons why Egypt prefers the Chinese vaccine, not to mention the fact that its production stages are subject to supervision and evaluation by the World Health Organization (WHO). But perhaps as well as is described below, the UAE has issued an emergency use authorization for the Sinopharm inactivated COVID-19 vaccine."

https://www.trialsitenews.com/sputnik-v-vs-sinopharms-vaccines-egypt-purportedly-opting-for-sinopharm/

Stock

2020-10-19 19:35 | Report Abuse

"After Jiaxing city in East China's Zhejiang Province announced on Thursday to gradually roll out COVID-19 vaccines for emergency use, covering ordinary people who voluntarily take the injections, more cities in the province began advancing the COVID-19 vaccination for urgent use, as the onset of the autumn-winter season raises the risks of respiratory diseases.

However, approving the COVID-19 vaccination for emergency use does not mean China is allowing the general public access to vaccine injections, as some Western media like the New York Times and the Wall Street Journal have reported, which also suggested that China is giving unproven vaccines on a large scale to ordinary people or students who go abroad to boost confidence in homegrown inoculations. Such interpretation of the latest policies on COVID-19 vaccines contradicts the reality and smears China's anti-epidemic efforts.

Compared to vaccines developed in the US and the UK, some experts noted that CHINA INDEED HAS HIGHER LEVEL OF SAFETY, especially after the trial of the vaccine developed by AstraZeneca and University of Oxford was put on hold in September and Johnson & Johnson also suspended its trial recently because a volunteer fell ill.

Zheng Zhongwei, an official from the National Health Commission who is in charge of technology development, told a forum in July that China has confidence in vaccine safety and in its effectiveness.

Following full demonstration and under the premise of compliance with the law, China officially launched the emergency use of COVID-19 vaccines on July 22 in a scientific and safe manner with informed as well as voluntary consent.

"No one who took the injection and worked in areas with severe outbreaks got infected, which also shows the vaccination was effective to some extent," Zheng was quoted as saying in media reports. "

https://www.globaltimes.cn/content/1203847.shtml

Stock
Stock

2020-10-19 19:05 | Report Abuse

"The most concerning of those are the unexplained illnesses that occurred with participants in AstraZeneca's late-stage study of AZD1222 in the U.K. and J&J's late-stage study of JNJ-78436735. Although the U.S. trial of AZD1222 remains paused, regulators in other countries, including the U.K., Japan, and South Africa, have allowed AstraZeneca to resume late-stage studies. There aren't enough details available yet related to J&J's clinical trial pause to know how long it might last.

All of the other side effects reported for these coronavirus vaccine candidates in earlier clinical trials resolved relatively quickly. This also appears to be the case in the late-stage studies. For example, CNBC recently interviewed some participants in phase 3 clinical trials evaluating Moderna's and Pfizer's coronavirus vaccine candidates. These participants reported experiencing side effects including "high fever, body aches, bad headaches, and exhaustion." However, all of them said those issues went away after no more than a day."

https://www.fool.com/investing/2020/10/13/coronavirus-vaccine-side-effects-3-key-things-you/

Stock

2020-10-19 17:48 | Report Abuse

@kukubesi thanks for your prayer. We all need it haha

Stock

2020-10-19 17:33 | Report Abuse

Yes, no operator YET, they are probably still waiting for vaccine to be approved first. Hope my patience pays off. I am willing to wait until December.

Stock

2020-10-19 17:14 | Report Abuse

This stock is not for trading, more for investing.

Stock

2020-10-19 17:12 | Report Abuse

Wah suddenly fly due to gloves??

Stock

2020-10-19 17:09 | Report Abuse

I know its frustrating but Im also waiting patiently because there will come a time when the Sinopharm vaccine will be approved by November/ December. Then only the magic starts to happen.

Stock

2020-10-19 16:51 | Report Abuse

@kukubesi lol you can talk cock all you want nobody believes you and nobody wants you here kekeke Maybe thats why our nickname is kukubesi = pemerintah yang kejam kekeke

Stock
Stock

2020-10-19 16:38 | Report Abuse

Nothing better to do? kekeke

Stock

2020-10-19 16:37 | Report Abuse

Lol so why are you here if you are so skeptical?

Stock

2020-10-19 16:22 | Report Abuse

@kukubesi oh wait you are also in LKL, another glove counter kekeke

Stock

2020-10-19 16:21 | Report Abuse

@kukubesi lol if you claim they "tipu" why are you here in this forum? Care to share your evidence that all these is "fake announcment" ? I bet you dont have any evidence cos you are in glove counter HLT and trying to run down potential vaccine counter lol so obvious kekeke